Cross-linked bioactive hydrogel matrices
View Patent ↗The present invention is directed to a stabilized cross-linked hydrogel matrix comprising a first high molecular weight component and a second high molecular weight component that are covalently linked, and at least one stabilizing or enhancing agent, wherein the first high molecular weight component and the second high molecular weight component are each selected from the group consisting of polyglycans and polypeptides. This stabilized hydrogel matrix may be prepared as bioactive gels, pastes, slurries, cell attachment scaffolds for implantable medical devices, and casting or binding materials suitable for the construction of medical devices. The intrinsic bioactivity of the hydrogel matrix makes it useful as a gel or paste in multiple applications, including as a cell attachment scaffold that promotes wound healing around an implanted device, as gels and pastes for induction of localized vasculogenesis, wound healing, tissue repair, and regeneration, as a wound adhesive, and for tissue bulking.
1. A method for promoting tissue regeneration in mammals comprising the steps of:
identifying a specific site in need of tissue regeneration; and
administering a therapeutically effective amount of a cross-linked bioactive hydrogel matrix to the identified site;
wherein the bioactive hydrogel matrix comprises a polyglycan covalently cross-linked to a polypeptide and further comprising at least one enhancing agent selected from the group consisting of polar amino acids, divalent cation chelators, and combinations thereof; wherein the polyglycan is a polysaccharide or a sulfated polysaccharide selected from the group consisting of glycosaminoglycans, glucosaminoglycans, dextran, heparan, heparin, hyaluronic acid, alginate, agarose, carageenan, amylopectin, amylose, glycogen, starch, cellulose, chitin, heparan sulfate, chondroitin sulfate, dextran sulfate, dermatan sulfate, and keratan sulfate; wherein the polypeptide is a tissue-derived polypeptide selected from the group consisting of collagens, gelatins, keratin, decorin, aggrecan, glycoproteins, laminin, nidogen, fibulin, and fibrillin; and wherein the covalently cross-linked hydrogel matrix is a solid or semi-solid material at physiological temperature and physiological pH.
2. The method of claim 1 , wherein said administering step comprises administering the hydrogel matrix at a vascular terminus, wherein the hydrogel matrix is positioned such that the matrix extends laterally from the vascular terminus.
3. The method of claim 1 , wherein the hydrogel matrix is cross-linked prior to administration.
4. The method of claim 1 , wherein the hydrogel matrix is cross-linked in situ.
5. The method of claim 1 , wherein the polyglycan has a molecular weight of about 2,000 to about 8,000,000 Da.
6. The method of claim 1 , wherein the polypeptide is a tissue-derived polypeptide derived from extracts of tissue, wherein the tissue is selected from the group consisting of submucosal tissues, arteries, vocal chords, pleura, trachea, bronchi, pulmonary alveolar septa, ligaments, auricular cartilage, abdominal fascia, liver, kidney, neurilemma, arachnoid, dura mater, and pia mater.
7. The method of claim 1 , wherein the polypeptide has a molecular weight of about 3,000 to about 3,000,000 Da.
8. The method of claim 1 , wherein the polyglycan is dextran and the polypeptide is gelatin.
9. The method of claim 1 , wherein the at least one enhancing agent comprises at least one polar amino acid selected from the group consisting of tyrosine, cysteine, serine, threonine, asparagine, glutamine, aspartic acid, glutamic acid, arginine, lysine, histidine, and mixtures thereof.
10. The method of claim 1 , wherein the at least one enhancing agent comprises ethylenediaminetetraacetic acid or a salt thereof.
11. The method of claim 1 , wherein the tissue in need of regeneration is vascular tissue.
12. The method of claim 1 , wherein the tissue in need of regeneration is bone.
13. The method of claim 12 , wherein the bioactive hydrogel matrix further comprises an osteoconductive or osteoinductive material.
14. The method of claim 13 , wherein the osteoconductive or osteoinductive material is selected from the group consisting of calcium alum inate, hydroxyapatite, alumina, zirconia, aluminum silicates, calcium phosphate, bioactive glass, ceramics, collagen, autologous bone, allogenic bone, xenogenic bone, coralline, and derivates or combinations thereof.
15. A method for promoting tissue regeneration in mammals comprising the steps of:
identifying a specific site in need of tissue regeneration; and
administering a therapeutically effective amount of a cross-linked bioactive hydrogel matrix to the identified site;
wherein the bioactive hydrogel matrix comprises a polyglycan covalently cross-linked to a polypeptide between functional groups on the polypeptide and functional groups on the polyglycan or with a bifunctional cross-linker molecule, and wherein the bioactive hydrogel matrix further comprises at least one enhancing agent selected from the group consisting of polar amino acids, divalent cation chelators, and combinations thereof.
16. The method of claim 15 , wherein the tissue in need of regeneration is vascular tissue.
17. The method of claim 15 , wherein the tissue in need of regeneration is bone.
18. The method of claim 17 , wherein the bioactive hydrogel matrix further comprises an osteoconductive or osteoinductive material.
19. The method of claim 18 , wherein the osteoconductive or osteoinductive material is selected from the group consisting of calcium aluminate, hydroxyapatite, alumina, zirconia, aluminum silicates, calcium phosphate, bioactive glass, ceramics, collagen, autologous bone, allogenic bone, xenogenic bone, coralline, and combinations thereof.